Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Operating Expenses (2016 - 2026)

Usana Health Sciences has reported Operating Expenses over the past 17 years, most recently at $176.9 million for Q2 2026.

  • Quarterly Operating Expenses fell 2.49% to $176.9 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $682.5 million through Apr 2026, up 5.26% year-over-year, with the annual reading at $687.0 million for FY2026, 9.57% up from the prior year.
  • Operating Expenses was $176.9 million for Q2 2026 at Usana Health Sciences, up from $173.0 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $248.3 million in Q1 2022 and troughed at $145.4 million in Q3 2024.
  • The 5-year median for Operating Expenses is $167.9 million (2024), against an average of $171.5 million.
  • Year-over-year, Operating Expenses tumbled 35.97% in 2022 and then grew 13.35% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $159.0 million in 2022, then fell by 2.79% to $154.5 million in 2023, then rose by 7.96% to $166.8 million in 2024, then decreased by 1.93% to $163.6 million in 2025, then increased by 8.11% to $176.9 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Operating Expenses are $176.9 million (Q2 2026), $173.0 million (Q1 2026), and $163.6 million (Q3 2025).